Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Kerstan

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Cutting edge: distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cellsAndreas Kerstan, Thomas Hünig
Experimental Dermatology|July 16, 2009
Effector pathways during eczematous dermatitis: where inflammation meets cell deathAndreas Kerstan, Martin Leverkus, Axel Trautmann
Archives of Dermatological Research|May 10, 2011
Decisive role of tumor necrosis factor-α for spongiosis formation in acute eczematous dermatitisAndreas Kerstan, E-B Bröcker, A Trautmann
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 9, 2015
Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effectiveJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Dermatology (Basel, Switzerland)|June 6, 2015
Kerinokeratosis Papulosa of ChildhoodBoris Bauer, Matthias Goebeler, Benedikt Weissbrich, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2012
Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedemaJohanna Stoevesandt, Johannes Hain, Andreas Kerstan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 26, 2018
Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implicationsJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 4, 2014
Risk stratification of systemic allergic reactions during Hymenoptera venom immunotherapy buildup phaseJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2012
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosisGesa Weise, Markus Hupp, Andreas Kerstan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Cyclosporin A abolishes CD28-mediated resistance to CD95-induced apoptosis via superinduction of caspase-3Andreas Kerstan, Nicole Armbruster, Martin Leverkus, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Cutting edge: distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cellsAndreas Kerstan, Thomas Hünig
Experimental Dermatology|July 16, 2009
Effector pathways during eczematous dermatitis: where inflammation meets cell deathAndreas Kerstan, Martin Leverkus, Axel Trautmann
Archives of Dermatological Research|May 10, 2011
Decisive role of tumor necrosis factor-α for spongiosis formation in acute eczematous dermatitisAndreas Kerstan, E-B Bröcker, A Trautmann
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 9, 2015
Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effectiveJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Dermatology (Basel, Switzerland)|June 6, 2015
Kerinokeratosis Papulosa of ChildhoodBoris Bauer, Matthias Goebeler, Benedikt Weissbrich, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2012
Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedemaJohanna Stoevesandt, Johannes Hain, Andreas Kerstan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 26, 2018
Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implicationsJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 4, 2014
Risk stratification of systemic allergic reactions during Hymenoptera venom immunotherapy buildup phaseJohanna Stoevesandt, Christine Hosp, Andreas Kerstan, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 23, 2012
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosisGesa Weise, Markus Hupp, Andreas Kerstan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Cyclosporin A abolishes CD28-mediated resistance to CD95-induced apoptosis via superinduction of caspase-3Andreas Kerstan, Nicole Armbruster, Martin Leverkus, et al.
Pageof 6